Published in Contemp Top Lab Anim Sci on November 01, 2001
Correction--not opposed to USDA inspections. Contemp Top Lab Anim Sci (2002) 0.75
If you had a magic wand. . . Contemp Top Lab Anim Sci (2001) 4.63
Insurance-related differences in the risk of ruptured appendix. N Engl J Med (1994) 6.69
Access to prenatal care following major Medicaid eligibility expansions. JAMA (1993) 3.04
Control of regional blood flow by endothelium-derived nitric oxide. Hypertension (1990) 2.93
Differences in hospital resource allocation among sick newborns according to insurance coverage. JAMA (1991) 2.59
Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol (1990) 2.58
Opioid users' attitudes towards and use of NHS clinics, general practitioners and private doctors. Br J Addict (1986) 2.18
Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes (1978) 2.04
An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun (1996) 1.99
Health service use among low-risk newborns after early discharge with and without nurse home visiting. J Am Board Fam Pract (1997) 1.97
Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol (1991) 1.90
Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol (1990) 1.80
Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol (1990) 1.77
Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats? Am J Physiol (1990) 1.74
Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol (1990) 1.72
Serial abuse in children who are shaken. Am J Dis Child (1990) 1.62
Regional hemodynamic effects of endothelin-1 in conscious, unrestrained, Wistar rats. J Cardiovasc Pharmacol (1989) 1.61
The effect of adrenaline upon cardiovascular and metabolic functions in man. Clin Sci (Lond) (1985) 1.58
An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl. Br J Pharmacol (1970) 1.57
Propofol and fentanyl compared with midazolam and fentanyl during third molar surgery. J Oral Maxillofac Surg (1998) 1.51
The adrenergic nervous system of the domestic fowl (Gallus domesticus [L.]). Z Zellforsch Mikrosk Anat (1970) 1.45
Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J (1998) 1.44
Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol (1991) 1.40
Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev (1992) 1.38
The use of gamma cameras to measure the disposition and fate of iodide in the rabbit [proceedings]. Br J Pharmacol (1978) 1.38
Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats. Clin Sci (Lond) (1985) 1.38
Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J (1995) 1.37
The Saccharomyces cerevisiae RAD9 checkpoint reduces the DNA damage-associated stimulation of directed translocations. Mol Cell Biol (1998) 1.36
The Schizosaccharomyces pombe cwg2+ gene codes for the beta subunit of a geranylgeranyltransferase type I required for beta-glucan synthesis. EMBO J (1993) 1.35
Cardiovascular control in diabetes mellitus. Br Med J (1975) 1.34
Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol (1988) 1.32
Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry (1976) 1.31
The involvement of noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit. Pflugers Arch (1976) 1.29
Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats. J Auton Nerv Syst (1988) 1.27
Cardiovascular reflex responses to apnoeic face immersion and mental stress in diabetic subjects. Cardiovasc Res (1976) 1.27
Successful isolation of a rat chromosome 1 blood pressure quantitative trait locus in reciprocal congenic strains. Hypertension (1998) 1.26
Antagonistic effect of human alpha-CGRP [8-37] on the in vivo regional haemodynamic actions of human alpha-CGRP. Biochem Biophys Res Commun (1990) 1.25
A study of nexuses in visceral smooth muscle. J Cell Biol (1969) 1.25
Diabetic autonomic neuropathy. Diabetes (1978) 1.25
Nerve-mediated excitation and inhibition of the smooth muscle cells of the avian gizzard. J Physiol (1969) 1.24
Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats. Life Sci (1991) 1.23
Regional hemodynamic responses to adrenoceptor antagonism in conscious rats. Am J Physiol (1988) 1.22
A search for the evidence supporting community paediatric practice. Arch Dis Child (1999) 1.22
Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats. Br J Pharmacol (1992) 1.20
Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol (2002) 1.20
The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol (1991) 1.18
Studies on the avian gizzard: the development of the gizzard and its innervation. Z Zellforsch Mikrosk Anat (1969) 1.17
Saccharomyces cerevisiae rad51 mutants are defective in DNA damage-associated sister chromatid exchanges but exhibit increased rates of homology-directed translocations. Genetics (2001) 1.17
NG-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur J Pharmacol (1989) 1.16
Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats. Br J Pharmacol (1994) 1.16
Expression of Saccharomyces cerevisiae MATa and MAT alpha enhances the HO endonuclease-stimulation of chromosomal rearrangements directed by his3 recombinational substrates. Mutat Res (1999) 1.16
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15
Regional hemodynamic effects of calcitonin gene-related peptide. Am J Physiol (1989) 1.15
Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol (1991) 1.12
Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin. Br J Pharmacol (1990) 1.11
Post-exercise reduction of blood pressure in hypertensive men is not due to acute impairment of baroreflex function. Clin Sci (Lond) (1984) 1.11
The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol (1992) 1.11
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol (2001) 1.10
Cardiac baroreflex sensitivities in conscious, unrestrained, Long Evans and Brattleboro rats. J Auton Nerv Syst (1988) 1.10
Incidence of impact trauma with cranial injuries ascribed to shaking. Am J Dis Child (1990) 1.09
Haemodynamic effects of the bacterial quorum sensing signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone, in conscious, normal and endotoxaemic rats. Br J Pharmacol (2001) 1.07
Cardiovascular responses to lower body negative pressure in normal subjects and in patients with diabetes mellitus. Cardiovasc Res (1979) 1.07
Fluorescence histochemical and ultrastructural observations on the effects of intravenous injections of vinblastine on noradrenergic nerves. Z Zellforsch Mikrosk Anat (1973) 1.06
Regulation of CD28 costimulation in human CD8+ T cells. J Immunol (1997) 1.06
Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br J Pharmacol (1994) 1.06
Hypoglycaemia, hypothermia and shivering in man. Clin Sci (Lond) (1981) 1.06
Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol (1995) 1.06
The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats. Br J Pharmacol (1991) 1.05
The impact of alcohol and alcohol expectancies on male perception of female sexual arousal in a date rape analog. Exp Clin Psychopharmacol (2001) 1.05
Regional hemodynamic effects of endothelin-2 and sarafotoxin-S6b in conscious rats. Am J Physiol (1990) 1.05
Is exercise good for high blood pressure? Br Med J (Clin Res Ed) (1982) 1.04
Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur J Pharmacol (1992) 1.03
Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. Br J Pharmacol (2001) 1.01
Effects of surgical operation and bed rest on cardiovascular responses to exercise in hospital patients. Cardiovasc Res (1973) 1.00
Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats. Clin Sci (Lond) (1990) 1.00
Regional hemodynamic changes following hypovolemia in conscious rats. Am J Physiol (1989) 1.00
Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats. Br J Pharmacol (1991) 0.99
Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J Pharmacol (1999) 0.99
Regional haemodynamic effects of human alpha- and beta-calcitonin gene-related peptide in conscious Wistar rats. Br J Pharmacol (1989) 0.99
The neuronal and extra-neuronal localisations of biogenic amines in the cervical region of the domestic fowl (Gallus gallus domesticus L.). Z Zellforsch Mikrosk Anat (1971) 0.98
Systemic arterial hypertension in rats exposed to short-term isolation; intra-arterial systolic and diastolic blood pressure and baroreflex sensitivity. Med Biol (1980) 0.97
Epithelial inclusion cyst of iris after keratoplasty. Am J Ophthalmol (1974) 0.97
The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men. Br J Clin Pharmacol (1984) 0.96
Medical examiner data in injury surveillance: a comparison with death certificates. Am J Epidemiol (1994) 0.96
Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats. Br J Pharmacol (1991) 0.96
Influence of the CB(1) receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats. Br J Pharmacol (2002) 0.96
Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. Br J Pharmacol (1995) 0.95
Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats. Br J Pharmacol (1991) 0.95
Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats. Br J Pharmacol (2004) 0.94
Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats. Br J Pharmacol (1992) 0.94
Insulin-like growth factor (IGF) and IGF binding protein gene expression in multicystic renal dysplasia. J Am Soc Nephrol (1997) 0.93
Effects of a hair cell transcription factor, Brn-3.1, gene deletion on homozygous and heterozygous mouse cochleas in adulthood and aging. Hear Res (1999) 0.93
Cardiovascular responses to graded reductions of central blood volume in normal subjects and in patients with diabetes mellitus. Clin Sci (Lond) (1980) 0.93
Stress as a diagnostic challenge for postconcussive symptoms: sequelae of mild traumatic brain injury or physiological stress response. Clin Neuropsychol (2001) 0.93
Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. Br J Pharmacol (1995) 0.93
Blood pressure in streptozotocin-treated Brattleboro and Long-Evans rats. Am J Physiol (1990) 0.92
Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats. Br J Pharmacol (1993) 0.92
Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats. Br J Pharmacol (1991) 0.92
Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats. Br J Pharmacol (1995) 0.92
The impact of prescribing on the crimes of opioid users. Br J Addict (1986) 0.92